{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:36:08Z","timestamp":1787610968623,"version":"build-2736575974"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ijcha.2022.101132","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T09:08:15Z","timestamp":1665392895000},"page":"101132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP \u2013 A narrative review"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4071-8960","authenticated-orcid":false,"given":"Brian","family":"Kerr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Brandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijcha.2022.101132_b0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke."},{"issue":"5","key":"10.1016\/j.ijcha.2022.101132_b0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study","volume":"113","author":"Stewart","year":"2002","journal-title":"Am J Med."},{"issue":"14","key":"10.1016\/j.ijcha.2022.101132_b0015","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/eurheartj\/ehs469","article-title":"All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995\u20132008: a Swedish nationwide long-term case\u2013control study","volume":"34","author":"Andersson","year":"2013","journal-title":"Eur Heart J."},{"issue":"5","key":"10.1016\/j.ijcha.2022.101132_b0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/clc.22272","article-title":"Management of Patients With Atrial Fibrillation by Primary-Care Physicians in Germany: 1-Year Results of the ATRIUM Registry","volume":"37","author":"Kirchhof","year":"2014","journal-title":"Clin Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2022.101132_b0025","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ahj.2014.02.003","article-title":"Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)","volume":"167","author":"Steinberg","year":"2014","journal-title":"Am Heart J."},{"issue":"9961","key":"10.1016\/j.ijcha.2022.101132_b0030","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of \u03b2 blockers in patients with heart failure plus atrial fibrillation: An individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet."},{"issue":"9","key":"10.1016\/j.ijcha.2022.101132_b0035","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.114.302226","article-title":"Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression","volume":"114","author":"Heijman","year":"2014","journal-title":"Circ Res."},{"key":"10.1016\/j.ijcha.2022.101132_b0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijcard.2015.10.089","article-title":"An update on atrial fibrillation in 2014: From pathophysiology to treatment","volume":"203","author":"Ferrari","year":"2016","journal-title":"Int J Cardiol."},{"issue":"2","key":"10.1016\/j.ijcha.2022.101132_b0045","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0008-6363(02)00258-4","article-title":"Electrical, contractile and structural remodeling during atrial fibrillation","volume":"54","author":"Allessie","year":"2002","journal-title":"Cardiovasc Res."},{"issue":"9","key":"10.1016\/j.ijcha.2022.101132_b0050","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial Fibrillation","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ Res."},{"key":"10.1016\/j.ijcha.2022.101132_b0055","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijcard.2015.07.057","article-title":"High-density mapping of atrial fibrillation in a chronic substrate: Evidence for distinct modes of repetitive wavefront propagation","volume":"199","author":"Kuklik","year":"2015","journal-title":"Int J Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2022.101132_b0060","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/CIRCEP.115.003324","article-title":"Letter by Jalife et al Regarding Article, \u201cQuantitative Analysis of Localized Sources Identified by Focal Impulse and Rotor Modulation Mapping in Atrial Fibrillation\u201d","volume":"8","author":"Jalife","year":"2015","journal-title":"Circ Arrhythmia Electrophysiol."},{"issue":"4","key":"10.1016\/j.ijcha.2022.101132_b0065","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/cvr\/cvq336","article-title":"Time course and mechanisms of endo-epicardial electrical dissociation during atrial fibrillation in the goat","volume":"89","author":"Eckstein","year":"2011","journal-title":"Cardiovasc Res."},{"issue":"6","key":"10.1016\/j.ijcha.2022.101132_b0070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/clc.22667","article-title":"Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact","volume":"40","author":"Dilaveris","year":"2017","journal-title":"Clin Cardiol."},{"issue":"7","key":"10.1016\/j.ijcha.2022.101132_b0075","first-page":"7","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J."},{"issue":"2","key":"10.1016\/j.ijcha.2022.101132_b0080","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1023\/A:1009823001707","article-title":"Clinical relevance of silent atrial fibrillation: Prevalence, prognosis, quality of life, and management","volume":"4","author":"Savelieva","year":"2000","journal-title":"J Interv Card Electrophysiol."},{"issue":"26","key":"10.1016\/j.ijcha.2022.101132_b0085","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial Fibrillation in Patients with Cryptogenic Stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N Engl J Med."},{"issue":"2","key":"10.1016\/j.ijcha.2022.101132_b0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.amjcard.2019.04.027","article-title":"Thromboembolism in the Absence of Atrial Fibrillation","volume":"124","author":"Smietana","year":"2019","journal-title":"Am J Cardiol."},{"issue":"February","key":"10.1016\/j.ijcha.2022.101132_b0095","first-page":"1","article-title":"Atrial Cardiomyopathy: An Unexplored Limb of Virchow\u2019s Triad for AF Stroke Prophylaxis","volume":"7","author":"Darlington","year":"2020","journal-title":"Front Cardiovasc Med."},{"issue":"26","key":"10.1016\/j.ijcha.2022.101132_b0100","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic Stroke and Underlying Atrial Fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1016\/j.ijcha.2022.101132_b0105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(15)70027-X","article-title":"Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis","volume":"14","author":"Sposato","year":"2015","journal-title":"Lancet Neurol."},{"issue":"21","key":"10.1016\/j.ijcha.2022.101132_b0110","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.ijcha.2022.101132_b0115","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythmia Electrophysiol."},{"issue":"4","key":"10.1016\/j.ijcha.2022.101132_b0120","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1474-4422(17)30002-9","article-title":"Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AF RANDOMISED): an open-label randomised controlled trial","volume":"16","author":"Wachter","year":"2017","journal-title":"Lancet Neurol."},{"issue":"14","key":"10.1016\/j.ijcha.2022.101132_b0125","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.117.028845","article-title":"Subclinical Atrial Fibrillation in Older Patients","volume":"136","author":"Healey","year":"2017","journal-title":"Circulation."},{"issue":"26","key":"10.1016\/j.ijcha.2022.101132_b0130","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","article-title":"Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices","volume":"36","author":"Martin","year":"2015","journal-title":"Eur Heart J."},{"issue":"1","key":"10.1016\/j.ijcha.2022.101132_b0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/eurheartj\/ehw119","article-title":"Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation","volume":"38","author":"Spronk","year":"2017","journal-title":"Eur Heart J."},{"issue":"4","key":"10.1016\/j.ijcha.2022.101132_b0140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.joa.2016.05.002","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication","volume":"32","author":"Goette","year":"2016","journal-title":"J Arrhythmia."},{"key":"10.1016\/j.ijcha.2022.101132_b0145","article-title":"Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation","author":"Boriani","year":"2019","journal-title":"EP Eur."},{"issue":"Supplement_2","key":"10.1016\/j.ijcha.2022.101132_b0150","first-page":"ii14","article-title":"Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future","volume":"23","author":"Heijman","year":"2021","journal-title":"EP Eur."},{"issue":"7","key":"10.1016\/j.ijcha.2022.101132_b0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15829\/1560-4071-2017-7-7-86","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"147","author":"Kirchhof","year":"2017","journal-title":"Russ J Cardiol."},{"issue":"8","key":"10.1016\/j.ijcha.2022.101132_b0160","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/14779072.2017.1355238","article-title":"Atrial cardiopathy: a mechanism of cryptogenic stroke","volume":"15","author":"Yaghi","year":"2017","journal-title":"Expert Rev Cardiovasc Ther."},{"issue":"8","key":"10.1016\/j.ijcha.2022.101132_b0165","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1161\/ATVBAHA.116.307545","article-title":"N-Terminal Pro-B-Type Natriuretic Peptide Is Related to Retinal Microvascular Damage: The Rotterdam Study","volume":"36","author":"Mutlu","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"6","key":"10.1016\/j.ijcha.2022.101132_b0170","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00392-014-0674-6","article-title":"Association of multiple biomarkers and classical risk factors with early carotid atherosclerosis: results from the Gutenberg Health Study","volume":"103","author":"Sinning","year":"2014","journal-title":"Clin Res Cardiol."},{"issue":"7","key":"10.1016\/j.ijcha.2022.101132_b0175","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/STROKEAHA.110.580837","article-title":"Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis Risk in Communities Study","volume":"41","author":"Yatsuya","year":"2010","journal-title":"Stroke."},{"issue":"10","key":"10.1016\/j.ijcha.2022.101132_b0180","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0301-5629(02)00573-2","article-title":"Carotid artery intima-media thickness and plaque score for the risk assessment of stroke subtypes","volume":"28","author":"Nagai","year":"2002","journal-title":"Ultrasound Med Biol."},{"issue":"3","key":"10.1016\/j.ijcha.2022.101132_b0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000083249","article-title":"Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke","volume":"19","author":"Nakagawa","year":"2005","journal-title":"Cerebrovasc Dis."},{"issue":"5","key":"10.1016\/j.ijcha.2022.101132_b0190","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.05.022","article-title":"Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke","volume":"151","author":"Iltumur","year":"2006","journal-title":"Am Heart J."},{"issue":"6","key":"10.1016\/j.ijcha.2022.101132_b0195","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1159\/000363279","article-title":"Plasma natriuretic peptides and incidence of subtypes of ischemic stroke","volume":"37","author":"Berntsson","year":"2014","journal-title":"Cerebrovasc Dis."},{"issue":"February","key":"10.1016\/j.ijcha.2022.101132_b0200","first-page":"1","article-title":"Promising Biomarker Candidates for Cardioembolic Stroke Etiology. A Brief Narrative Review and Current Opinion","volume":"12","author":"Markus","year":"2021","journal-title":"Front Neurol."},{"issue":"5","key":"10.1016\/j.ijcha.2022.101132_b0205","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1161\/STROKEAHA.114.008311","article-title":"B-Type Natriuretic Peptides Help in Cardioembolic Stroke Diagnosis","volume":"46","author":"Llombart","year":"2015","journal-title":"Stroke."},{"issue":"5","key":"10.1016\/j.ijcha.2022.101132_b0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2169\/internalmedicine.48.1475","article-title":"Plasma Brain Natriuretic Peptide Can be a Biological Marker to Distinguish Cardioembolic Stroke from Other Stroke Types in Acute Ischemic Stroke","volume":"48","author":"Shibazaki","year":"2009","journal-title":"Intern Med."},{"key":"10.1016\/j.ijcha.2022.101132_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-8-45","article-title":"Plasma brain natriuretic peptide as a surrogate marker for cardioembolic stroke","volume":"8","author":"Yukiiri","year":"2008","journal-title":"BMC Neurol."},{"issue":"2","key":"10.1016\/j.ijcha.2022.101132_b0220","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajem.2018.05.010","article-title":"Contribution of routine cardiac biological markers to the etiological workup of ischemic stroke","volume":"37","author":"Tomich","year":"2019","journal-title":"Am J Emerg Med."},{"issue":"4","key":"10.1016\/j.ijcha.2022.101132_b0225","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.01.012","article-title":"The Diagnostic Value of N-terminal Pro-brain Natriuretic Peptide in Differentiating Cardioembolic Ischemic Stroke","volume":"22","author":"Hajsadeghi","year":"2013","journal-title":"J Stroke Cerebrovasc Dis."},{"issue":"7","key":"10.1016\/j.ijcha.2022.101132_b0230","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2310\/6650.2005.53709","article-title":"Natriuretic Peptides in Acute and Chronic Kidney Disease and during Renal Replacement Therapy","volume":"53","author":"H\u00f6rl","year":"2005","journal-title":"J Investig Med."},{"issue":"9","key":"10.1016\/j.ijcha.2022.101132_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105730","article-title":"Chronic Kidney Disease is a Risk Factor for Stroke","volume":"30","author":"Wyld","year":"2021","journal-title":"J Stroke Cerebrovasc Dis."},{"issue":"22","key":"10.1016\/j.ijcha.2022.101132_b0240","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.jacc.2012.11.082","article-title":"N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: Insights from the aristotle trial (apixaban for the prevention of stroke in subjects with atrial fibrillation)","volume":"61","author":"Hijazi","year":"2013","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2022.101132_b0245","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/clc.22883","article-title":"NT-proBNP is associated with mortality and adverse cardiac events in patients with atrial fibrillation presenting to the emergency department","volume":"41","author":"Holl","year":"2018","journal-title":"Clin Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2022.101132_b0250","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1373\/jalm.2016.021477","article-title":"Score Using Measurements of Plasma Midregional Pro-Atrial Natriuretic Peptide to Estimate the Duration of Atrial Fibrillation","volume":"1","author":"Legallois","year":"2017","journal-title":"J Appl Lab Med."},{"issue":"7","key":"10.1016\/j.ijcha.2022.101132_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.119.012242","article-title":"Do the Natriuretic Peptides Cause Atrial Fibrillation or is it Not So Black and White?","volume":"8","author":"Richards","year":"2019","journal-title":"J Am Heart Assoc."},{"issue":"2","key":"10.1016\/j.ijcha.2022.101132_b0260","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15420\/aer.2013.2.2.109","article-title":"Natriuretic Peptides as Predictors of Atrial Fibrillation Recurrences Following Electrical Cardioversion","volume":"2","author":"Zografos","year":"2013","journal-title":"Arrhythmia Electrophysiol Rev."},{"issue":"6","key":"10.1016\/j.ijcha.2022.101132_b0265","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1161\/HYPERTENSIONAHA.115.05366","article-title":"Circulating C-Type Natriuretic Peptide and Its Relationship to Cardiovascular Disease in the General Population","volume":"65","author":"Sangaralingham","year":"2015","journal-title":"Hypertension."},{"issue":"June","key":"10.1016\/j.ijcha.2022.101132_b0270","first-page":"1","article-title":"CNP Signal Peptide in Patients with Cardiovascular Disease","volume":"2","author":"Lee","year":"2015","journal-title":"Front Cardiovasc Med."},{"issue":"1","key":"10.1016\/j.ijcha.2022.101132_b0275","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/clinchem\/hvaa287","article-title":"Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure","volume":"67","author":"Tan","year":"2021","journal-title":"Clin Chem."},{"issue":"3","key":"10.1016\/j.ijcha.2022.101132_b0280","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjcard.2007.11.011","article-title":"An International Consensus Statement Regarding Amino-Terminal Pro-B-Type Natriuretic Peptide Testing: The International NT-proBNP Consensus Panel","volume":"101","author":"Januzzi","year":"2008","journal-title":"Am J Cardiol."},{"issue":"2","key":"10.1016\/j.ijcha.2022.101132_b0285","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1071-9164(00)90010-1","article-title":"Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation","volume":"6","author":"Inoue","year":"2000","journal-title":"J Card Fail."},{"issue":"15","key":"10.1016\/j.ijcha.2022.101132_b0290","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/heartjnl-2014-306008","article-title":"Biomarkers and atrial fibrillation: is it prime time yet?","volume":"100","author":"Mahajan","year":"2014","journal-title":"Heart."},{"issue":"10","key":"10.1016\/j.ijcha.2022.101132_b0295","doi-asserted-by":"crossref","first-page":"934","DOI":"10.5603\/KP.a2014.0092","article-title":"The effect of strict rate control on B-type natriuretic peptide values and echocardiographic parameters in chronic atrial fibrillation","volume":"72","author":"Ozkurt","year":"2014","journal-title":"Kardiol Pol."},{"key":"10.1016\/j.ijcha.2022.101132_b0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijcard.2015.03.046","article-title":"Biomarkers of cardiomyocyte injury and stress identify left atrial and left ventricular remodelling and dysfunction: A population-based study","volume":"185","author":"Ravassa","year":"2015","journal-title":"Int J Cardiol."},{"issue":"11","key":"10.1016\/j.ijcha.2022.101132_b0305","doi-asserted-by":"crossref","first-page":"e013416","DOI":"10.1161\/JAHA.119.013416","article-title":"Atrial Tissue Pro-Fibrotic M2 Macrophage Marker CD163+, Gene Expression of Procollagen and B-Type Natriuretic Peptide","volume":"9","author":"Watson","year":"2020","journal-title":"J Am Heart Assoc."},{"issue":"5","key":"10.1016\/j.ijcha.2022.101132_b0310","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2174\/0929867324666170918122502","article-title":"Biomarkers Associated with Atrial Fibrosis and Remodeling","volume":"26","author":"Dilaveris","year":"2019","journal-title":"Curr Med Chem."},{"issue":"13","key":"10.1016\/j.ijcha.2022.101132_b0315","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.111.038729","article-title":"Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: A randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy","volume":"125","author":"Hijazi","year":"2012","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.ijcha.2022.101132_b0320","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.joa.2015.04.002","article-title":"Usefulness of brain natriuretic peptide for predicting left atrial appendage thrombus in patients with unanticoagulated nonvalvular persistent atrial fibrillation","volume":"31","author":"Ochiumi","year":"2015","journal-title":"J Arrhythmia."},{"issue":"10","key":"10.1016\/j.ijcha.2022.101132_b0325","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/europace\/eun206","article-title":"Atrial fibrillation down-regulates renal neutral endopeptidase expression and induces profibrotic pathways in the kidney","volume":"10","author":"Bukowska","year":"2008","journal-title":"Europace."},{"key":"10.1016\/j.ijcha.2022.101132_b0330","doi-asserted-by":"crossref","unstructured":"Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, Vasan RS. Association of Plasma Natriuretic Peptide Levels With Metabolic Risk Factors in Ambulatory Individuals. 2007.","DOI":"10.1161\/CIRCULATIONAHA.106.655142"},{"key":"10.1016\/j.ijcha.2022.101132_b0335","doi-asserted-by":"crossref","unstructured":"Alehagen U, Peter J, Dahlstr\u00f6m U. Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly \u2606. 2007;382:8\u201314.","DOI":"10.1016\/j.cca.2007.03.005"},{"key":"10.1016\/j.ijcha.2022.101132_b0340","first-page":"859","author":"Luchner","year":"2013","journal-title":"Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population : contribution of age, gender, and cardiac and extra-cardiac factors."},{"key":"10.1016\/j.ijcha.2022.101132_b0345","doi-asserted-by":"crossref","unstructured":"Staub D, Jonas N, Zellweger MJ, Nusbaumer C, Wild D, Pfisterer ME, et al. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia. 2005.","DOI":"10.1016\/j.amjmed.2005.05.020"},{"key":"10.1016\/j.ijcha.2022.101132_b0350","doi-asserted-by":"crossref","unstructured":"Sabatine MS, Morrow DA, Lemos JA De, Omland T, Desai MY, Tanasijevic M, et al. Acute Changes in Circulating Natriuretic Peptide Levels in Relation to Myocardial Ischemia. J Am Coll Cardiol [Internet]. 2004;44(10):1988\u201395. Available from: http:\/\/dx.doi.org\/10.1016\/j.jacc.2004.07.057.","DOI":"10.1016\/j.jacc.2004.07.057"},{"issue":"5","key":"10.1016\/j.ijcha.2022.101132_b0355","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1586\/erc.12.31","article-title":"The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure","volume":"10","author":"Dandamudi","year":"2012","journal-title":"Expert Rev Cardiovasc Ther."},{"issue":"7","key":"10.1016\/j.ijcha.2022.101132_b0360","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death","volume":"350","author":"Wang","year":"2004","journal-title":"N Engl J Med [Internet]."},{"key":"10.1016\/j.ijcha.2022.101132_b0365","doi-asserted-by":"crossref","unstructured":"Patton KK, Heckbert SR, Alonso A, Bahrami H, Lima JAC, Burke G, et al. N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fi brillation in the Multi-Ethnic Study of Atherosclerosis\u00a0: the effects of age , sex and ethnicity. 2013;1832\u20136.","DOI":"10.1136\/heartjnl-2013-304724"},{"issue":"18","key":"10.1016\/j.ijcha.2022.101132_b0370","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.873265","article-title":"N-Terminal pro-b-type natriuretic peptide is a major predictor of the development of atrial fibrillation: The cardiovascular health study","volume":"120","author":"Patton","year":"2009","journal-title":"Circulation."},{"issue":"21","key":"10.1016\/j.ijcha.2022.101132_b0375","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jacc.2010.05.049","article-title":"Assessment of Conventional Cardiovascular Risk Factors and Multiple Biomarkers for the Prediction of Incident Heart Failure and Atrial Fibrillation","volume":"56","author":"Smith","year":"2010","journal-title":"J Am Coll Cardiol."},{"issue":"10","key":"10.1016\/j.ijcha.2022.101132_b0380","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/europace\/euu175","article-title":"B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: The CHARGE-AF Consortium of community-based cohort studies","volume":"16","author":"Sinner","year":"2014","journal-title":"Europace."},{"issue":"16","key":"10.1016\/j.ijcha.2022.101132_b0385","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/heartjnl-2016-310236","article-title":"N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation","volume":"103","author":"Svennberg","year":"2017","journal-title":"Heart."},{"key":"10.1016\/j.ijcha.2022.101132_b0390","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ahj.2018.07.008","article-title":"Association of N-terminal pro B-type natriuretic peptide (NT-proBNP) change with the risk of atrial fibrillation in the ARIC cohort","volume":"204","author":"Li","year":"2018","journal-title":"Am Heart J."},{"key":"10.1016\/j.ijcha.2022.101132_b0395","doi-asserted-by":"crossref","unstructured":"Ghazal F, Theobald H, Rosenqvist M, Al-Khalili F. Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care. Lionetti V, editor. PLoS One. 2019 Feb 26;14(2):e0212974.","DOI":"10.1371\/journal.pone.0212974"},{"issue":"1","key":"10.1016\/j.ijcha.2022.101132_b0400","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/europace\/euz255","article-title":"Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: The STROKESTOP II study","volume":"22","author":"Kemp Gudmundsdottir","year":"2020","journal-title":"Europace."},{"issue":"November","key":"10.1016\/j.ijcha.2022.101132_b0405","first-page":"1","article-title":"N-Terminal Pro B-Type Natriuretic Peptide\u2019s Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors","volume":"10","author":"Pal\u00e0","year":"2019","journal-title":"Front Neurol."},{"issue":"2","key":"10.1016\/j.ijcha.2022.101132_b0410","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/STROKEAHA.119.026496","article-title":"Brain Natriuretic Peptide and Discovery of Atrial Fibrillation After Stroke","volume":"51","author":"Wasser","year":"2020","journal-title":"Stroke."},{"key":"10.1016\/j.ijcha.2022.101132_b0415","doi-asserted-by":"crossref","unstructured":"Fonseca AC, Brito D, e Melo TP, Geraldes R, Canh\u00e3o P, Caplan LR, et al. N -Terminal Pro-Brain Natriuretic Peptide Shows Diagnostic Accuracy for Detecting Atrial Fibrillation in Cryptogenic Stroke Patients. Int J Stroke. 2014 Jun 26;9(4):419\u201325.","DOI":"10.1111\/ijs.12126"},{"issue":"2","key":"10.1016\/j.ijcha.2022.101132_b0420","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijcard.2006.11.230","article-title":"Head-to-head comparison of B-type natriuretic peptide (BNP) and NT-proBNP in daily clinical practice","volume":"124","author":"Mair","year":"2008","journal-title":"Int J Cardiol."},{"issue":"6","key":"10.1016\/j.ijcha.2022.101132_b0425","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcla.20146","article-title":"Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea","volume":"20","author":"Sanz","year":"2006","journal-title":"J Clin Lab Anal."},{"issue":"12","key":"10.1016\/j.ijcha.2022.101132_b0430","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/clc.20478","article-title":"Serum N-terminal-pro-Brain Natriuretic Peptide Level and Its Clinical Implications in Patients with Atrial Fibrillation","volume":"32","author":"Bai","year":"2009","journal-title":"Clin Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2022.101132_b0435","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/bmm.09.47","article-title":"Comparison of the cardiac markers B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide","volume":"3","author":"Buchner","year":"2009","journal-title":"Biomark Med."},{"issue":"1","key":"10.1016\/j.ijcha.2022.101132_b0440","first-page":"5","article-title":"BNP or NTproBNP?","volume":"129","author":"Steiner","year":"2008","journal-title":"A clinician\u2019s perspective. Int J Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2022.101132_b0445","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cardfail.2006.09.003","article-title":"The Biologic Variability of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Stable Heart Failure Patients","volume":"13","author":"O\u2019Hanlon","year":"2007","journal-title":"J Card Fail."},{"issue":"7","key":"10.1016\/j.ijcha.2022.101132_b0450","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.02.014","article-title":"Predicting Cardioembolic Stroke with the B-Type Natriuretic Peptide Test: A Systematic Review and Meta-analysis","volume":"23","author":"Yang","year":"2014","journal-title":"J Stroke Cerebrovasc Dis."},{"issue":"5","key":"10.1016\/j.ijcha.2022.101132_b0455","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1161\/STROKEAHA.114.008311","article-title":"B-Type Natriuretic Peptides Help in Cardioembolic Stroke Diagnosis","volume":"46","author":"Llombart","year":"2015","journal-title":"Stroke."},{"issue":"2","key":"10.1016\/j.ijcha.2022.101132_b0460","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/ene.14579","article-title":"B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke","volume":"28","author":"Pal\u00e0","year":"2021","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.ijcha.2022.101132_b0465","doi-asserted-by":"crossref","unstructured":"Wachter R, Lahno R, Haase B, Weber-Kr\u00fcger M, Seegers J, Edelmann F, et al. Natriuretic Peptides for the Detection of Paroxysmal Atrial Fibrillation in Patients with Cerebral Ischemia \u2013 the Find-AF Study. Samuel J-L, editor. PLoS One [Internet]. 2012 Apr 11;7(4):e34351. Available from: https:\/\/dx.plos.org\/10.1371\/journal.pone.0034351.","DOI":"10.1371\/journal.pone.0034351"},{"issue":"11","key":"10.1016\/j.ijcha.2022.101132_b0470","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1080\/00207454.2017.1408612","article-title":"Detection of cardioembolic stroke with B-type natriuretic peptide or N-terminal pro-BNP: a comparative diagnostic meta-analysis","volume":"128","author":"Bai","year":"2018","journal-title":"Int J Neurosci."},{"issue":"2","key":"10.1016\/j.ijcha.2022.101132_b0475","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/1747493018799981","article-title":"The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods","volume":"14","author":"Kamel","year":"2019","journal-title":"Int J Stroke."},{"issue":"1","key":"10.1016\/j.ijcha.2022.101132_b0480","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/WNL.0000000000008692","article-title":"Stroke of undetermined cause and cardiomyopathies: Another piece of the puzzle?","volume":"94","author":"De Freitas","year":"2020","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.ijcha.2022.101132_b0485","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1161\/STROKEAHA.119.028669","article-title":"Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial","volume":"51","author":"Ntaios","year":"2020","journal-title":"Stroke."},{"key":"10.1016\/j.ijcha.2022.101132_b0490","unstructured":"Kamel H, Jr WTL, Tirschwell DL, Kronmal RA, Broderick JP, Palesch YY, et al. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial\u00a0: Rationale and methods. 2018;0(0):1\u20138."},{"issue":"14","key":"10.1016\/j.ijcha.2022.101132_b0495","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med."},{"issue":"19","key":"10.1016\/j.ijcha.2022.101132_b0500","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906722001816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906722001816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:13:42Z","timestamp":1762492422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906722001816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":100,"alternative-id":["S2352906722001816"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2022.101132","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP \u2013 A narrative review","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2022.101132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101132"}}